Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 481 to 495 of 662 results for diabetes

  1. Type 2 diabetes: insulin degludec (ESNM4)

    This evidence summary has been updated and replaced by NICE advice ESNM25.

    Withdrawn advice

  2. Type 1 diabetes: insulin degludec (ESNM5)

    This evidence summary has been updated and replaced by NICE advice ESNM24.

    Withdrawn advice

  3. Diabetes: annual psychological assessment (children) (IND57)

    This indicator has been updated and replaced by NICE indicator 313 and NICE indicator 314.

    Withdrawn indicator

  4. Diabetes: thyroid disease screening (children) (IND56)

    This indicator has been updated and replaced by NICE indicator 312.

    Withdrawn indicator

  5. Diabetes: annual smoking status (children) (IND55)

    This indicator has been updated and replaced by NICE indicator 310 and NICE indicator 311.

    Withdrawn indicator

  6. Diabetes: annual foot examination (children) (IND54)

    This indicator has been updated and replaced by NICE indicator 308 and NICE indicator 309.

    Withdrawn indicator

  7. Diabetes: annual eye screening (children) (IND53)

    This indicator has been updated and replaced by NICE indicator 306 and NICE indicator 307.

    Withdrawn indicator

  8. Diabetes: annual urinary albumin (children) (IND52)

    This indicator has been updated and replaced by NICE indicator 304 and NICE indicator 305.

    Withdrawn indicator

  9. Diabetes: annual blood pressure (children) (IND51)

    This indicator has been updated and replaced by NICE indicator 302 and NICE indicator 303.

    Withdrawn indicator

  10. Diabetes: annual care processes (children) (IND48)

    This indicator has been updated and replaced by NICE indicator 296 and NICE indicator 297.

    Withdrawn indicator

  11. Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia (TA343)

    Evidence-based recommendations on obinutuzumab (Gazyvaro) with chlorambucil for untreated chronic lymphocytic leukaemia in adults.

    Technology appraisal guidance
    Published
    2 June 2015
    View recommendations

    Sections for TA343

  12. Pyelonephritis (acute): antimicrobial prescribing (NG111)

    This guideline sets out an antimicrobial prescribing strategy for acute pyelonephritis (upper urinary tract infection) in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance.

    Antimicrobial prescribing guideline
    Published
    31 October 2018
    View recommendations

    Sections for NG111

  13. Kendall DL for ECG monitoring in people having cardiac surgery (MIB177)

    NICE has developed a medtech innovation briefing (MIB) on Kendall DL for ECG monitoring in people having cardiac surgery .

    Medtech innovation briefing
    Published
    18 March 2019

  14. RenalSense Clarity RMS for acute kidney injury (MIB256)

    NICE has developed a medtech innovation briefing (MIB) on RenalSense Clarity RMS for acute kidney injury .

    Medtech innovation briefing
    Published
    6 April 2021

  15. Macimorelin for diagnosing growth hormone deficiency (MIB320)

    NICE has developed a medtech innovation briefing (MIB) on macimorelin for diagnosing growth hormone deficiency .

    Medtech innovation briefing
    Published
    28 March 2023